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Intrauterine growth retardation (IUGR) aggravates the course
of acute mesangioproliferative glomerulonephritis (GN) in
the rat. Observational studies in children suggest that IUGR
may be associated with a severe course of kidney diseases
such as IgA nephropathy. We tested the hypothesis that IUGR
leads to aggravation of acute mesangioproliferative GN in
former IUGR rats. IUGR was induced in Wistar rats by
isocaloric protein restriction in pregnant dams. Litter size was
reduced to six male neonates in low protein animals (LP) and
normal protein animals (NP). At 8 weeks GN was induced by
injection of an anti-Thy-1.1 antibody. Rats were killed on days
4 and 14 after induction of GN and kidneys were investigated
for inflammation and sclerosis using real-time polymerase
chain reaction and histological methods. On day 4 after
induction of GN, LP animals showed more glomerulosclerosis
and tubulointerstitial lesions. On day 14, inflammatory
markers (expression of monocyte chemoattractant protein 1,
osteopontin, tumor necrosis factor and interleukin-6),
extracellular matrix accumulation and markers of sclerosis
(plasminogen activator inhibitor-1 expression, transforming
growth factor-b1 expression, score for glomerulosclerosis,
glomerular deposition of collagen I and collagen IV) were
more severe in LP animals. Some degree of induction of
inflammatory and profibrotic markers was also present in
non-nephritic LP animals. However, these rats did not display
marked glomerulosclerosis or interstitial fibrosis. We
conclude that after IUGR inflammatory damage is aggravated
and the reparation of the kidney is impaired during the
course of acute mesangioproliferative GN, leading to more
sclerotic lesions.
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Intrauterine growth retardation (IUGR) is a risk factor for
the development of a metabolic syndrome later in life.1–3 In
former IUGR individuals, type II diabetes, hypertension,
hyperlipidemia, and cardiovascular disease occur more
frequently than in individuals with normal birth weight.4,5
Moreover, a higher incidence of end-stage renal disease at
adulthood was described in patients with former IUGR,6,7
which, at least in part, can be attributed to the higher
incidence of metabolic diseases, like diabetes type II or
hypertension.
On the other hand, there is increasing evidence for an
association of IUGR and glomerular disease in children
independent of a pre-existing metabolic disease. Three
retrospective analyses found a greater incidence of complica-
tions and an unfavorable progression of nephrotic syndrome
in children with IUGR.8–10 IgA nephropathy is one of the
most frequent renal diseases during childhood. Children with
IUGR showing birth weight below the 10th percentile for the
respective gestational age were shown to be at higher risk to
develop progressive glomerulosclerosis during this disease
compared to children without IUGR.11 Little is known about
potential pathways linking IUGR and the later progression of
inflammatory renal diseases. Therefore, we tested the
hypothesis that IUGR leads to a more severe course of
glomerular disease.
Of the different animal models of IUGR,12,13 we chose the
low protein (LP) diet model in the rat, which is widely
used.14–18 IUGR is induced in the offspring by protein
restriction to half or less of the normal protein (NP) content
to the pregnant dams. Most often this prenatal protein
restriction is followed by NP content in post-natal diet
modeling the change between prenatal restriction of nutri-
tion supply and adequate post-natal nutrition.13 Typical
aspects of this model are reduced birth weight, development
of arterial hypertension in later life, and a reduced glomerular
number.13 As a model for renal inflammation, we selected
acute mesangioproliferative glomerulonephritis (GN) in rats.
This form of GN is initiated by injection of an anti-Thy-1.1
antibody causing a self limiting GN with features reminiscent
of human IgA nephropathy.19,20 We hypothesized that IUGR
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influences the course of GN in later life owing to a reduced
regeneration capacity.
RESULTS
IUGR – non-nephritic animals
LP diet of the pregnant dams led to a reduction of birth
weight and body length of their offspring at birth in
comparison to litters of NP fed dams (Table 1). The total
number of animals per litter was not different (16.070.8
pups in NP mothers versus 15.071.3 pups in LP mothers,
P¼ 0.61). Until day 12 after birth, however, the offspring of
the mothers fed LP diet caught up with the offspring of
mothers with normal 17% protein diet (NP). At the age of 8
weeks, the body weight of LP and NP was comparable
(Table 1). At day 70, mean arterial blood pressure was not
different in LP and NP animals (Table 1). There was no
development of proteinuria and no significant difference in
endogenous creatinine clearance (Table 1). Relative kidney
weight was not different on day 70 (Table 1).
The total number of glomeruli per kidney was about 27%
lower in LP than in NP (Table 1). Total glomerular volume
and mean glomerular volume were not different. Thus, total
filtration area per kidney was lower in LP animals than in NP
animals (Table 1).
Looking for early profibrotic and inflammatory cytokine
expression at day 70, we detected a significant induction in
the mRNA expression of transforming growth factor-b1(TGF-
b1) (3.6870.56 fold induction in LP, Po0.05) and
plasminogen activator inhibitor-1 (PAI-1) (2.5470.58 fold
induction in LP, Po0.05), as well as osteopontin (OPN)
(2.5870.50 fold induction in LP, Po0.05), monocyte
chemoattractant protein 1 (MCP-1) (2.8270.34 fold induc-
tion in LP, Po0.05) and tumor necrosis factor (TNF)
(3.7571.48 fold induction in LP, Po0.05) mRNA expression
in LP. At day 70 (Figure 1, upper panels) minimal signs of
glomerulosclerosis could be detected by semiquantitative
scoring in LP (glomerulosclerosis index (GSI): 0.1170.03 in
NP versus 0.3970.03 in LP; Po0.01). Scoring for tubulo-
interstitial lesions showed no differences at day 70 (data not
shown). To exclude cell proliferation in the glomerulus, we
analyzed the number of proliferating cell nuclear antigen
(PCNA)-positive glomerular cells, which was similar in LP
and NP (0.1670.03 PCNA-positive cells/glomerulus in non-
nephritic NP and 0.1670.05 in non-nephritic LP). OPN and
MCP-1 induction at day 70 was neither followed by an
increased glomerular (0.8570.11 cells/glomerulus in NP
Table 1 | Physiological and stereological data of control animals and animals with IUGR
NP LP
Birth weight (g) 6.470.1 5.670.12*
Body length at birth (cm) 5.070.03 4.870.04*
Body weight at the time of induction of GN=week 8 (g) 316.273.89 317.776.62
Urinary protein excretion (mg/24 h/100 g BWT) 4.0570.58 5.0876.43
Creatinine clearance (ml/h/100 g BWT) 37.7774.82 31.9072.05
Creatinine clearance (ml/h/1000 glomeruli) 2.8370.55 2.9170.31
Mean arterial pressure (mm Hg) 105.371.64 101.372.69
Relative kidney weight (mg/g BWT) 4.0470.09 3.9870.17
Number of glomeruli/kidney 54 96072231 40 37072638*
Total glomerular volume (mm3) 44.8773.16 37.3775.47
Mean glomerular volume ( 103mm3) 817.2754.92 907.6789.23
Glomerular filtration area per kidney (mm2) 172.1720.0 104.5713.5*
IUGR, intrauterine growth retardation; LP, low protein; NP, normal protein.
Values are given as means7s.e.m.
*Po0.05 versus NP. LP, growth-retarded rats (mothers fed LP diet during pregnancy). NP, control rats (mothers fed NP diet during pregnancy).
Data for body weight at birth, body length at birth, and body weight at the time of induction of GN are given from animals of all groups (NP, n=22, LP, n=21).
All other data are given from the day 70 animals (NP d70, n=12, LP d70, n=11).
Six NP d70 and five LP d70 animals were randomly selected for stereological analysis.
Figure 1 | Representative photomicrographs of glomeruli of LP
(born with growth retardation) and NP rats (born with normal
weight). D70, control group without GN, killed at the age of 70 days.
GN d4, rats 4 days after induction of GN; GN d14, rats 14 days after
induction of GN (original magnification  400, PAS’s staining).
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versus 0.7770.06 cells/glomerulus in LP) nor by an incre-
ased interstitial (2.5370.12 cells/interstitial cross-section in
NP versus 2.7672.20 cells/interstitial cross-section in LP)
macrophage infiltration cells staining positive for mouse
monoclonal anti-rat monocyte-like macrophage antibody
(ED-1-positive cells) in LP animals. No differences in the depo-
sition of glomerular collagen IV could be detected between
LP and NP animals at day 70 (14.371.9% per glomerular
cross-section in NP versus 17.872.0% in LP).
Onset of anti-Thy-1.1 nephritis (GN) – day 4 of GN
The induction of mesangioproliferative GN was followed by
proteinuria, microaneurysm formation, inflammation,
macrophage infiltration, cell proliferation, mild glomerulo-
sclerosis, and tubulointerstitial damage (Figure 1, middle
panels). In response to anti-Thy-1.1 injection NP and LP
animals developed proteinuria. Nevertheless, proteinuria was
not different between LP and NP (Table 2). Endogenous
creatinine clearance per 1000 glomeruli as surrogate for renal
function was significantly lower in nephritic LP animals
(Table 2). Mean arterial blood pressure was not increased in
nephritic LP animals (Table 2) compared to NP.
To quantify the extent of complement-mediated mesan-
giolysis after anti-Thy-1.1 injection, we scored microaneu-
rysm formation. As expected, glomerular microaneurysms
were detected in both LP and NP at day 4 of disease (see
Figure 1, middle panels), being equally distributed in both
groups (score for microaneurysms 0.7770.09 in NP and
0.9470.24 in LP animals, not significant). As an important
feature in the course of Anti-Thy-1.1 nephritis, we analyzed
the early proinflammatory cytokine pattern in renal cortex.
The mRNA expression of MCP-1, the inflammatory cytokine
interleukin-6, TNF, and OPN (Figure 2) in LP was not
different to NP. As a consequence, glomerular and interstitial
infiltration by macrophages measured by ED-1-positive
staining was similar in LP and NP (Table 2). As a marker
for glomerular cell proliferation we analyzed the number of
PCNA-positive cells per glomerulus at day 4 of GN showing
similar cell proliferation in NP and LP (Table 2). For the
detection of early changes in the induction of fibrotic lesions,
we analyzed the cortical mRNA expression of TGF-b1, PAI-1,
and collagen I. At this early stage of GN expression levels were
comparable in NP and LP (Figure 3). Nevertheless,
Table 2 | Proteinuria, creatinine clearance, mean arterial blood pressure, relative kidney weight, glomerular cell proliferation,
macrophage infiltration, and stereological data of rats at days 4 and 14 of GN
NP+GN d4 LP+GN d4 NP+GN d14 LP+GN d14
Urinary protein excretion (mg/24 h/100 g BWT) 5.3570.58 8.8272.85 20.1876.92 17.1472.30
Endogen creatinine clearance (ml/h/100 g BWT) 85.3674.82 70.7873.83* 53.1971.89 63.2371.90*
Endogen creatinine clearance (mg/h/1000 glomeruli) 7.6970.80 10.9870.60* 5.9070.59 10.2577.48*
Mean arterial blood pressure (mm Hg) 100.374.65 115.072.85 99.277.02 121.377.48
Relative kidney weight (mg/g BWT) 4.0370.13 4.1470.15 3.7270.08 4.6770.25*
Glomerular cell proliferation (PCNA-positive cells/glomerular cross section) 5.6670.67 4.8570.91 0.8570.18 1.2470.26
Glomerular macrophage infiltration (ED-1-positive cells/glomerular cross-section) 5.7270.60 6.2371.81 1.6870.11 1.0770.07*
Interstitial macrophage infiltration/ED-1-positive cells/cross-section) 4.3170.67 4.6871.94 3.2670.84 2.8670.34
Number of glomeruli/kidney 36 96072183 23 40071066* 33 45072705 22 38071292*
Total glomerular volume (mm3) 37.7773.78 22.7871.12* 26.0674.18 30.3771.41
Mean glomerular volume ( 103mm3) 1016771.98 982780.63 807.17138.1 1366761.94*
Glomerular filtration area per kidney (mm2) 155.3735.47 165.7712.37 79.23715.0 68.3878.12
BWT, body weight; d4, day 4; d14, day 14; GN, glomerulonephritis; LP, low protein; NP, normal protein; PCNA, proliferating cell nuclear antigen.
Values are given as means 7s.e.m. LP animals were always compared to their corresponding NP group.
*Po0.05 LP versus NP. LP, growth-retarded rats (mothers fed LP diet during pregnancy). NP, control rats (mothers fed NP diet during pregnancy).
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Figure 2 | Expression of markers of inflammation in the
renal cortex of rats at days 4 (d4) and 14 (d14) of GN. LP,
growth-retarded rats (mothers fed LP diet during pregnancy).
All values are normalized to the corresponding NP group (control
rats with GN, mothers fed NP diet during pregnancy). Expression
of the (a) chemokine MCP-1, (b) chemokine OPN,
(c) proinflammatory cytokine TNF, and (d) proinflammatory cytokine
interleukin-6. *Po0.05 LP versus NP.
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glomerulosclerosis, measured by GSI and tubulointerstitial
damage (score for tubulointerstitial lesions) were more severe
in nephritic LP animals compared to the nephritic NP group
(GSI: 0.1270.03 in NP and 0.7170.12 in LP, Po0.01,
tubulointerstitial lesion score: 0.3270.03 in NP and
0.7570.13 in LP) (see Figure 1, middle panels). In this early
phase of GN, glomerular collagen I and collagen IV
deposition was not different between nephritic LP and NP
animals (Figure 4a and b). Interstitial collagen I deposition
was lower in NP compared to LP animals (Figure 4c).
The total number of glomeruli was significantly lower in
LP animals compared to NP animals on day 4 (Table 3). Total
glomerular volume was reduced in nephritic LP animals,
whereas the mean glomerular volume was similar in both
groups. Glomerular filtration area per kidney was not
different at day 4 of GN.
Prolongation of inflammation and fibrosis in LP – day 14 of GN
After 14 days of GN, urinary protein excretion was higher
compared to the animals with GN at day 4. LP animals
showed no higher protein excretion than NP animals
(Table 2). Renal function according to endogenous creatinine
clearance was slightly higher in LP than in NP animals at day
14 of GN (Table 2). Mean arterial blood pressure was slightly
higher in LP animals than in NP animals without reaching
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Figure 3 | Expression of profibrotic markers and collagen I in the
renal cortex of rats at days 4 (d4) and 14 (d14) of GN. LP,
growth-retarded rats (mothers fed LP diet during pregnancy). All
values are normalized to the corresponding NP group (control rats
with GN, mothers fed NP diet during pregnancy). Expression of
(a) TGF-b1, (b) collagen I, and (c) PAI-1. *Po0.05 LP versus NP.
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Figure 4 | Glomerular and interstitial collagen deposition in rats
at days 4 (d4) and 14 (d14) of GN. NP, control rats (mothers fed NP
diet during pregnancy), LP, growth-retarded rats (mothers fed LP diet
during pregnancy). Positive area for (a) glomerular collagen I per
glomerular cross-section (%), (b) glomerular collagen IV per
glomerular cross-section (%), (c) interstitial collagen I per glomerular
cross-section. *Po0.05, **Po0.01.
Table 3 | Designed primer pairs and TaqMan probes used in
this study
MCP-1 Forward: 50-CCTCCACCACTATGCAGGTCTC-30
Reverse: 50-GCACGTGGATGCTACAGGC-30
Probe: 50(FAM)-TCACGCTTCTGGGCCTGTTGTTCA-(TAMRA)30
OPN Forward: 50-AAAGTGGCTGAGTTTGGCAG-30
Reverse: 50-AAGTGGCTACAGCATCTGAGTGT-30
Probe: 50(FAM)-TCAGAGGAGAAGGCGCATTACAGCA-
(TAMRA)30
PAI-1 Forward: 50-TCCGCCATCACCAACATTTT-30
Reverse: 50-GTCAGTCATGCCCAGCTTCTC-30
Probe: 50(FAM)-CCGCCTCCTCATCCTGCCTAAGTTCTCT-
(TAMRA)30
IL-6 Forward: 50-TCCAAACTGGATATAACCAGGAAAT-30
Reverse: 50-TTGTCTTTCTTGTTATCTTGTAAGTTGTTCTT-30
Probe: 50(FAM)-AATCTGCTCTGGTCTTCTGGAGTTCGGTTTCTA-
(TAMRA)30
TNF Forward: 50-GACCCTCACACTCAGATCATCTTCT-30
Reverse: 50-TTGTCTTTGAGATCCATGCCATT-30
Probe: 50(FAM)-ACGTCGTAGCAAACCACCAAGCGGA-
(TAMRA)30
TGF-b1 Forward: 50-CACCCGCGTGCTAATGGT-30
Reverse: 50-GGCACTGCTTCCCGAATG-30
Probe: 50(FAM)-ACCGCAACAACGCAATCTATGACA-(TAMRA)30
GAPDH Forward: 50-ACGGGAAACCCATCACCAT-30
Reverse: 50-CCAGCATCACCCCATTTGA-30
Probe: 50(FAM)-TTCCAGGAGCGAGATCCCGTCAAG-TAMRA)30
PBGD Forward: 50-AGACCATGCAGGCCACCA-30
Reverse: 50-CAACCAACTGTGGGTCATCCT-30
Probe: 50(FAM)-AGGTCCCTGTTCAGCAAGAAGATGGTCC-
(TAMRA)30
b-Actin Forward: 50-TGAGCTGCCTGACGGTCAG-30
Reverse: 50-TGCCACAGGATTCCATACCC-30
Probe: 50(FAM)-CACTATCGGCAATGAGCGGTTCCG-(TAMRA)30
Collagen-Ia Forward: 50-GACGCAGAAGTCATAGGAGTC-30
Reverse: 50-GGAAGTCCAGGCTGTCCA G-30
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IL-6, interleukin-6; MCP-1,
monocyte chemoattractant protein 1; OPN, osteopontin; PAI-1, plasminogen
activator inhibitor-1; PBGD, porphobilinogen-deaminase; TGF-b1, transforming
growth factor-b1; TNF, tumor necrosis factor.
aCollagen I was detected by SYBR Green analysis.
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statistical significance. Relative kidney weight was signifi-
cantly higher in LP animals on day 14 of GN (Table 3).
Glomeruli of both NP and LP were still hypercellular,
showed matrix expansion and formation of extracapillary
proliferates (Figure 1, lower panels). The number of
microaneurysms had decreased in all animals compared to
day 4. There was still a significant higher microaneurysm
score index in nephritic LP animals (0.3370.03 in LP versus
0.0670.01 in NP, Po0.01), showing a slower reparation of
microaneurysms. A higher mRNA expression of inflamma-
tory mediators was detected in nephritic LP day 14 as
compared to nephritic NP day 14. Expression of MCP-1
(Figure 2a) and OPN (Figure 2b) as well as expression of the
inflammatory cytokines TNF (Figure 2c) and interleukin-6
(Figure 2d) was significantly higher at day 14 of disease. This
prolongation of the inflammatory response in LP corre-
sponded with a prolonged expression of fibrotic markers.
Expression of the profibrotic cytokine TGF-b (Figure 3a), the
PAI-1 (Figure 3c), and collagen I (Figure 3b) was significantly
higher in LP than in NP. Assessment of the GSI revealed a
significantly higher score in LP compared to NP (1.770.1 in
LP versus 1.270.1 in NP, Po0.05). Moreover, LP rats tended
to have a higher index for tubulointerstitial damage
(1.270.04 in LP versus 0.671.7 in NP, P¼ 0.056) and more
extracapillary proliferates (6.971.4% of glomeruli affected in
LP versus 2.971.7% in NP, P¼ 0.15). The increased mRNA
expression of collagen I resulted in an enhanced deposition of
collagen I in the glomeruli of LP rats (Figure 4a). There was
no difference of interstitial collagen I and glomerular collagen
IV deposition in both groups (Figure 4c and b). The number
of glomerular PCNA-positive cells was not different in LP
and NP animals at day 14 of GN. Glomerular macrophage
infiltration was significantly lower in LP animals (Table 2).
No difference was found for interstitial macrophage infiltra-
tion at day 14 of GN.
The total number of glomeruli was significantly lower in
LP animals, total glomerular volume was similar in both
groups, and mean glomerular volume in LP animals was
significantly higher compared to NP animals at day 14 of GN
(Table 2). Glomerular filtration area per kidney was not
different in LP animals compared to NP animals on day 14
(Table 2).
DISCUSSION
IUGR is discussed as an independent risk factor for the later
development of metabolic, cardiovascular, and renal dis-
ease.21 Until now only a few observational studies analyzed
the course of glomerular diseases like idiopathic nephrotic
syndrome and IgA nephropathy in children in relation to
their birth weight.8–11 We studied the course of acute anti-
Thy-1.1 GN in rats with IUGR. As a model of IUGR, we
chose maternal protein restriction during gestation. In
contrast to other IUGR models like bilateral uterine artery
ligation, no disturbed glucose tolerance or development of
diabetes in young animals can be detected.12 Because placenta
insufficiency is an important cause for IUGR in humans,
bilateral uterine artery ligation was considered to more
closely resemble human IUGR in Western countries.22
Protein malnutrition of dams may be seen as an equivalent
for maternal protein malnutrition in developing countries.13
A special feature of nutritional models is the change between
poor prenatal and optimal post-natal environment.13 Human
data of, for example, Barker et al.23 show the importance on
early childhood weight gain in the development of coronary
heart disease. Because kidney development is completed on
day 8 of life in rats, post-natal environment influences kidney
development and nephron number.24 Both models of IUGR
show a reduced number of glomeruli,25 arterial hypertension
in later life,13 and renal fibrosis.26–28 We used a model of mild
protein restriction (8%) throughout gestation in Wistar dams
and reduced litter size to six males to standardize post-natal
growth and nutritional impact on post-natal renal develop-
ment. Our findings of a reduced number of glomeruli in LP
animals are in line with the published literature. Despite a
lower number of glomeruli in LP animals, total glomerular
volume and mean glomerular volume was not different in
our study. The total number of glomeruli obtained from our
study was surprisingly higher than those reported by other
techniques in the literature27,28 and this may be due to the
use of a design-based method for estimation of glomerular
number. However, the difference in glomerular number
between NP and LP should not be affected by this technical
point. In GN animals, stereometric analysis revealed a lower
number of glomeruli. The relation between LP and NP was
untouched by this. Intraindividual variability and loss of
glomeruli by GN may be an explanation.
Until the age of 10 weeks, LP animals developed no
elevated blood pressure. As early as 8 weeks of age, LP
animals showed increased mRNA-expression levels of
inflammatory and profibrotic markers. Nevertheless, the
expression of inflammatory markers in non-nephritic IUGR
rats was mild, compared to nephritic animals, and did not
lead to progressive glomerulosclerosis or interstitial scarring,
at least not in the time frame of our experiment. More
pronounced renal damage may develop at a later stage,
accompanied by a higher blood pressure.27
In a rat model of acute mesangioproliferative GN, a single
injection of anti-Thy-1.1 antibody causes an acute, comple-
ment-mediated mesangiolysis lasting for 2 days approxi-
mately. This is followed by mesangial proliferation and
overproduction of mesangial matrix during days 3–10. In
contrast to human mesangioproliferative GN, the acute anti-
Thy-1.1 model results in almost complete remission.19 For
the evaluation of the course of anti-Thy-1.1 GN in former
IUGR rats, we choose day 4 as an early time point with
microaneurysm formation and mesangial cell proliferation.
On day 14 of disease, reparation is almost accomplished.19 In
our study, there was no difference in the initial mesangiolytic
and inflammatory response during the early phase of GN
(day 4) between LP and NP animals. On day 14 of GN, LP
animals showed higher mRNA expression of inflammatory
and profibrotic markers, more glomerulosclerosis and more
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extracellular matrix deposition in the glomeruli than NP
animals. These findings may indicate a transition from an
acute form of mesangioproliferative GN into a chronic-
progressive form.29 In fact, some histological features on day
14 of our study resemble the findings in chronic progressive
anti-Thy-1.1 GN induced by a single injection of a 1-22-3
antibody and consecutive uninephrectomy.30 Light micro-
scopic findings in uninephrectomized animals showed
glomerular hypertrophy, severe mesangial cell proliferation,
tubular atrophy, and even extracapillary proliferations. But in
contrast to the findings in our study, these lesions were found
as late as day 84 after induction of GN.30 GN induces an
increase of endogenous creatinine clearance in both LP and
NP animals, with significantly higher values in LP animals.
This may indicate consecutive hyperfiltration under stress
conditions like in GN. These findings go in line with an
increase of the mean glomerular volume in LP animals at day
14 of GN.
Comparing former IUGR children to normal children
with later IgA nephropathy Zidar et al.11 found more
glomerulosclerosis and crescent formation in children with
IUGR. Although this study did not analyze clinical outcome,
glomerulosclerosis and crescent formation are negative
prognostic markers in the course of IgA nephropathy.31
Keeping in mind all restrictions of an animal model, some
aspects of anti-Thy-1.1 GN resemble IgA nephropathy.
Prolonged inflammation and disturbed reparation in LP
animals with GN mimic the histopathologic picture of IgA
nephropathy in children being born too small for gestational
age. The aggravated course of acute mesangioproliferative
GN in rats being born with IUGR underlines the association
between IUGR and glomerular inflammation and reparation.
It provides the opportunity to examine disturbed glomerular
inflammation processes in IUGR animals in detail.
Nephron mass reduction is a common feature in IUGR
models.25,27 Nephrogenesis is directly disturbed by perinatal
environmental changes like malnutrition, reduced placental
perfusion, or blockade of renin-angiotensin system.25,32,33
Reduced nephron mass, consecutive hyperfiltration, and
nephron endowment are discussed as mechanistic link
between low birth weight and adult hypertension.21,34,35
For the induction of a chronic progressive anti-Thy-1.1 GN
in the rat nephron mass reduction is mandatory, too.29 Our
stereological data show lower glomerular filtration areas per
kidney in non-nephritic LP animals compared to NP.
Considering the lower number of glomeruli in LP animals,
filtration surface per glomerulus is equal in LP and NP
animals. Initial mesangiolytic reaction is similar in LP and
NP animals. This makes an effect of relatively higher antibody
doses binding to the glomerular surface unlikely. Reduced
nephron mass may facilitate induction of chronic progressive
lesions not only in a model of chronic progressive anti-Thy-
1.1 GN but also in our model of acute anti-Thy-1.1 GN after
IUGR. Nevertheless, the degree of nephron mass reduction
differs between both models. The pathway mediating this
phenomenon is not known to date. It is unlikely that
nephron mass reduction alone is the explanation for chronic
progressive lesions in anti-Thy-1.1 GN after IUGR.
We could identify an upregulation of TGF-b1 and PAI-1
expression on day 14 of GN in our study. Overexpression of
TGF-b120,36 and PAI-137 in earlier time points during the
course of acute anti-Thy-1.1 GN is well known. Nevertheless,
TGF-b1 and PAI-1 play an essential role in the induction of
progressive fibrotic lesions and renal scarring.38,39 In a model
of five-sixth nephrectomized rats, nephron mass reduction
per se leads to mRNA expression of profibrotic angiotensino-
gen and TGF-b1 by microvascular lesions as early as 24 h after
injury.40 In our study, IUGR without GN leads to an
upregulation of proinflammatory and profibrotic cytokine
mRNA around day 70. Although this upregulation did not
lead to pronounced glomerular and interstitial sclerosis at
this age, a progressive effect in the presence of a second renal
stressor like acute GN may be possible. However, further
experiments with surgical nephron mass reduction in NP
animals may help to define the role of nephron number and
TGF-b induction after IUGR more exactly.
Furthermore, the duration of anti-Thy-1.1 GN in our
study seems to be short for a relevant influence by mild
elevated blood pressure.41 Further experiments are needed to
characterize the role of the renin-angiotensin system and
catch-up growth in a possible programming of glomerular
inflammation response after IUGR.
We conclude that the course of acute mesangioprolifera-
tive GN in the rat is aggravated in former IUGR animals. This
observation provides evidence that the association between
IUGR and glomerulosclerosis in children with IgA nephro-
pathy is due to a cause-and-effect relationship. Further
studies are needed to elucidate possible mechanisms and
potential targets for therapy.
MATERIALS AND METHODS
Animal procedures
All procedures performed on animals were carried out in accordance
with guidelines of the American Physiological Society and were
approved by the local government authorities (Regierung von
Mittelfranken, AZ no. 621–2531.31–11/02 and AZ no.
621–2531.31–14/05). Virgin female Wistar rats were obtained from
an own colony and were housed in a room maintained at 22721C,
exposed to a 12 h dark/light cycle. The animals were allowed
unlimited access to standard chow (no. 1320, Altromin, Lage,
Germany) and tap water. Ten dams were time-mated by the
appearance of sperm plugs. They were fed a diet containing 17.0%
protein (casein) (NP) or an isocaloric diet containing 8.0% protein
(LP) throughout pregnancy. Diets were obtained from Altromin
(no. C1000, C1003). Sodium content (0.02%), fat content (5%),
total energy content (14.6 MJ/kg), vitamin content, mineral content,
and the relation of amino acids in both diets were equal. Rats
delivered spontaneously. On the first day of life, the litters were
reduced to six male pups per dam in both groups to provide similar
growth conditions. During lactation, rat mothers were fed standard
chow. The offspring was nursed by their own mothers until weaned
at day 23 to standard chow. At the age of 8 weeks, animals out of
four LP litters and six NP litters were randomly divided into six
groups for this study. To control age-dependent changes in the renal
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phenotype, non-nephritic LP and NP animals were killed at day 70
defining two control groups: LP diet, non-nephritic, age 70 days (LP
d70, n¼ 11), and NP diet, non-nephritic, age 70 days (NP d70,
n¼ 12). In the other animals, anti-Thy-1.1 GN was induced by a
single intravenous injection of 1 mg/kg body weight monoclonal
anti-Thy-1.1 antibody (ER4, Antibody Solutions, Palo Alto, CA,
USA) into the tail vein in light ether anesthesia as described before.42
Animals were killed 4 or 14 days after GN induction. Groups are
indicated as LPþGN day 4 (n¼ 5), NPþGN day 4 (n¼ 5),
LPþGN day 14 (n¼ 5), NPþGN day 14 (n¼ 5).
Twenty-four hours before killing, animals were housed in
individual metabolic cages to collect urine for quantification. Blood
samples were obtained at killing. At the day of killing starting at
0800 hours, all animals were instrumented with femoral catheters
for intra-arterial blood pressure measurements. Catheters were
implanted in the right femoral artery under anesthesia with 20 mg/
kg body weight ketamine (Ketavet, Pfizer GmbH, Tiergesundheit,
Karlsruhe, Germany) and 0.5 mg/kg medetomidin (Dormitor, Pfizer
GmbH) intraperitoneally. Catheters were tunneled subcutaneously
in order to prevent the rats from interfering with the catheters. At
the end of the operation, animals were antagonized with 0.2 ml
Atipamezol (5 mg/ml, Antisedan, Pfizer GmbH) and woke up within
3–5 min. Two hours after anesthesia, mean arterial blood pressure
was recorded on a polygraph (Hellige, Freiburg, Germany, FRG) in
conscious rats for 30 min in the animals’ homecages.
Protein and creatinine in serum and urine samples were analyzed
with the automatic analyzer Integra 800 (Roche Diagnostics,
Mannheim, Germany). Endogenous creatinine clearance was
calculated.
Tissue preparation
After arterial blood pressure measurement, the experiment was
terminated by retrograde perfusion via the abdominal aorta in deep
anesthesia with ketamine 100 mg/kg body weight and midazolame
5 mg/kg body weight intraperitoneally.43 First, the left kidney was
taken out and portions of the cortex were immediately snap-frozen
in liquid nitrogen for mRNA analysis. Another portion of renal
tissue was fixed in methyl-carnoy solution (60% methanol, 30%
chloroform, and 10% glacial acetic acid). After removing the left
kidney, the organs of the animals were perfusion fixed with 3%
glutaraldehyde for morphometric and stereological measurements as
described in detail elsewhere.43–45
Then, the right kidney was taken out, weighed, and dissected in a
plane perpendicular to the interpolar axis, yielding slices of 1 mm
width. Ten small pieces of each kidney were selected by area
weighted sampling for Epon-Araldite embedding.43–45 The remain-
ing tissue slices were embedded in paraffin, 4 mm sections were
taken, and stained with hematoxylin/eosin and periodic acid-Schiff
(PAS). Using area-weighted sampling, five of the resin blocks were
randomly selected from which semithin sections (0.8 mm) were
prepared and stained with methylene blue and basic fuchsin.
Subsequently, the paraffin and semithin sections were investigated
by morphometry and stereology46 in a blinded manner.
RNA extraction and real-time polymerase chain reaction
RNA was extracted from renal cortex using Trizol reagent
(Invitrogen, Paisley, Scotland, UK), according to the manufacturer’s
instructions. Quantitative real-time reverse transcriptase-polymer-
ase chain reaction analysis was performed as described previously47
for OPN, MCP-1, interleukin-6, TNF, PAI-1, and TGF-b1. Collagen I
mRNA expression was quantified using the SYBR Green method in a
Bio-Rad iQ5 I-Cycler with the IQ SYBR-Green Supermix (both from
Bio-Rad Laboratories, Hercules, CA, USA). In all probes, the relative
amount of the specific mRNA was normalized with respect to
porphobilinogen-deaminase. The results were confirmed by normal-
ization on other ‘housekeeping genes’ like b-actin or glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) and measurements were
performed twice, showing similar results (data not shown). Primer
pairs and TaqMan probes used are listed in Table 3. Unless otherwise
indicated, the oligonucleotides for each gene investigated were
designed by the use of Primer Express software (Perkin-Elmer,
Foster City, CA, USA), using uniform selection parameters that
allowed for the application of standard cycle conditions.
Kidney histology
The degree of mesangial matrix expansion and sclerosis within the
glomerular tuft as an index of progression was determined on PAS-
stained paraffin sections adopting the semiquantitative scoring
system (GSI) proposed by Nahas et al.48 Using light microscopy at a
magnification of  400, the glomerular score of each animal was
derived as the mean of 100 randomly sampled glomeruli. The
severity of glomerulosclerosis was expressed on an arbitrary scale
from 0 to 4. The glomerular score for individual glomeruli was:
grade 0, normal glomerulus; grade 1, presence of mesangial
expansion/thickening of the basement membrane; grade 2, mild/
moderate segmental hyalinosis/sclerosis involving less than 50% of
the glomerular tuft; grade 3, diffuse glomerular hyalinosis/sclerosis
involving more than 50% of the tuft; grade 4, diffuse glomerulo-
sclerosis with total tuft obliteration and collapse. The resulting index
in each animal was expressed as a mean of all scores obtained.
To determine the extent of the formation of microaneurysms,
capillary widening was scored on 100 randomly sampled glomeruli
using PAS-stained sections at a magnification of  400. A
semiquantitative scoring system (microaneurysm score index) was
applied with a score from 0 to 4.49 Score 0: no capillary widening in
the glomerular tuft; score 1: capillary widening involving up to 25%
of the glomerular tuft; score 2: capillary widening 25–50%; score 3:
capillary widening 50–75%; score 4: capillary widening involving
more than 75% of the glomerular tuft. The resulting index in each
animal was expressed as a mean of all scores obtained.
Tubulointerstitial damage, that is, tubular atrophy, tubular
dilatation, interstitial fibrosis, and interstitial inflammation, was
assessed on PAS-stained paraffin sections at a magnification of
 100, using a semiquantitative scoring system (tubulointerstitial
lesion score).44,45 For determination of the tubulointerstitial lesion
score, 10 fields per kidney were randomly sampled and graded as
follows: grade 0, no change; grade 1, lesions involving less than 25%
of the area; grade 2, lesions affecting 25–50%; grade 3, lesions
involving more than 50%; and grade 4, involving (almost) the entire
area.
Crescent formation (in %) was determined on PAS-stained
paraffin sections at a magnification of  400 as the mean of 100
randomly sampled glomeruli.
Glomerular geometry was assessed by point counting (100 point
eyepiece, Integrationsplatte II Zeiss Co., Oberkochen, Germany) on
paraffin sections (hematoxylin/eosin and PAS stain, light micro-
scopy, various magnifications) as follows:
Area (AA) and volume density (VV) of the renal cortex, and
medulla as well as the number of glomeruli per area (NA) were
measured using a Zeiss eyepiece (Integrationsplatte II, Zeiss Co.)
and the point counting method (PP¼AA¼VV) at a magnification of
 400 on hematoxylin/eosin sections.43–45 In addition, volume
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density (VV) of glomeruli and area density of glomerular tuft (AAT)
were also measured. Total area of the glomerular tuft was then
determined as AT¼AATAcortex. In addition, the number of
glomeruli per area (NA) was counted at a magnification of  100.
Glomerular number per area (NA) was then corrected for tissue
shrinkage. The number of glomeruli per volume (NV) and the
volume density (VV) of glomeruli was calculated using the following
formula: NV¼ k/bNA1.5/VV0.5 with k¼ 1 and b¼ 1.382. Total cortex
volume (Vcortex) was derived from kidney mass divided by the
specific weight of the kidney (1.04 g/cm3) times the volume density
of the cortex. The total number of glomeruli was derived from the
total volume of the renal cortex and the number of glomeruli per
cortex volume: Nglom¼NVVCortex. The mean glomerular volume
was then determined according to v¼ k/bAT1.5 with k¼ 1.1 and
b¼ 1.382.43–45
On five semithin sections per animal glomerular capillarization
and cellularity was analyzed using the point counting method and a
100 point eyepiece (Integrationsplatte II, Zeiss Co.) at a magnifica-
tion of  1000 (oil immersion) in at least 30 glomeruli as described
in detail previously.50 Briefly, the mean glomerular tuft volume was
determined according to v¼ b/kAT1.5 with b¼ 1.382 and k¼ 1.1.
The volume density (VV) and the number of cells per area (NA) were
determined and the number of cells per volume was determined
according to (NV): NV¼ k/bNA1.5/VV0.5 with b¼ 1.5 for podocytes
and b¼ 1.4 for mesangial and endothelial cells and k¼ 1. The
number of each cell type per glomerulus (Nglom) was then derived
from Nglom¼NV vglom. The mean cell volume (vC) of each cell
type was determined from volume density, mean glomerular volume,
and mean number of cells per glomerulus: vC¼VV vglom/Nglom.
Length density (LV) of glomerular capillaries, that is, the total
length of capillaries per unit glomerular volume, was determined
according to the standard stereological formula LV¼ 2QA (with QA
being the number of capillary transects per area of the capillary
tuft). Total length of glomerular capillaries per one kidney (Ltotal)
was then derived from LV and the total glomerular volume measured
using the semithin sections.
The total area of glomerular capillaries was derived from
AA(capillaries)AT. Glomerular filtration area per kidney was
calculated according to total area of glomerular capillaries times
total number of glomeruli per kidney.50
Immunohistochemistry
After overnight fixation in methyl-carnoy solution, tissues were
dehydrated by bathing in increasing concentrations of methanol,
followed by 100% isopropanol. After embedding in paraffin, 3 mm
sections were cut with a Leitz SM 2000 R microtome (Leica
Instruments, Nussloch, Germany). After deparaffinization, endo-
genous peroxidase activity was blocked with 3% H2O2 in methanol
for 20 min at room temperature. Glomerular and interstitial
collagen I was detected by a rabbit polyclonal antibody (Biogenesis,
Poole, England, UK) at a dilution of 1:1000. A goat polyclonal
antibody to collagen IV (Southern Biotechnology Associates,
Birmingham, AL, USA) was used at a dilution of 1:500. A mouse
monoclonal antibody detecting proliferating cells (PCNA) was
purchased from Dako (Hamburg, Germany) and used at a dilution
of 1:50. The mouse monoclonal antibody to macrophages (ED-1)
was from Serotec (Biozol, Eching, Germany) and diluted 1:250.
Immunohistochemistry was performed in deparaffinized sections
of methyl-carnoy-fixed kidneys, using an avidin horseradish
peroxidase detection system (Vector Lab, Burlingame, CA, USA)
as described before.51 As a negative control, we used equimolar
concentrations of preimmune rabbit or mouse immunoglobulin G.
Each slide was counterstained with hematoxylin.
Analysis of data
Proliferating cells (PCNA-positive cells) and macrophages (ED-1-
positive cells) were counted in 100 glomeruli and expressed as
positive cells per glomerular cross-section. To evaluate glomerular
collagen I and collagen IV, computer-based integration of stained
areas was performed in 20 randomly selected glomeruli per kidney
section (Metaview, Visitron Systems, Puchheim, Germany). The
average area staining positive for collagen I and collagen IV per
glomerular cross-section was calculated as a percentage of
glomerular cross-section.49
Tubulointerstitial collagen I content and ED-1-positive cells were
counted at a  400 magnification using the point counting method
and a 121 point eyepiece (Integrationsplatte II, Zeiss Co.). The
results are expressed as the mean of 20 randomly selected fields.
The results of reverse transcriptase-polymerase chain reaction
were calculated based on the DDCt method as described in detail
previously52 and expressed as fold induction of mRNA expression
compared to the corresponding NP animal groups. Messenger RNA
expression in NP animals was defined as 1.0-fold induction.
Two-tailed Mann–Whitney-test was used to test significance of
differences between LP and NP animals at the given time points. A
P-value less than 0.05 was considered significant. The procedures were
carried out using the Graph Pad Prism software (GraphPad Software,
San Diego, CA, USA). Values are displayed as means7s.e.m.
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